In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2. Shang W, Dai W, Yao C, Xu L, et al. Antiviral Res 2022;208:105450.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shang W, Dai W, Yao C, Xu L, et al. In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2. Antiviral Res 2022;208:105450.
PMID: 36354082